For adults with diabetes and obesity, GLP-1 RAs are associated with a reduced risk for obesity-related cancer compared with DPP-4 inhibitors.

Spinal cord stimulation can reduce pain and restore nerve function among patients with diabetic peripheral neuropathy.

Compounded vs non-compounded GLP-1 RA drug products are associated with an increased risk for adverse events such as nausea and diarrhea.

AI-assisted insulin titration was noninferior to endocrinologists in managing glycemic control among patients with type 2 diabetes.

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Certain air pollutants were associated with changes in metabolites among postmenopausal women in the US, potentially impacting bone health.

AACE released clinical guidelines on the diagnosis, management, and surveillance of tumors related to multiple endocrine ...

Early-life risk factors including lack of breastfeeding and low birth weight were associated with increased risk for adult-onset type 2 diabetes.

High-dose HCQ use may lower the risk for diabetes among patients with pSS and can potentially mitigate the diabetogenic effects of glucocorticoids.

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

A new White House report says today’s children are the sickest generation in U.S. history when it comes to chronic disease.